Treatment of hyperglycemia in patients with acute intracerebral hemorrhage: A Randomised Pilot Study.

Treatment of hyperglycemia in patients with acute intracerebral hemorrhage: A Randomised Pilot Study. - Treatment of hyperglycemia in patients with acute intracerebral hemorrhage.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010079

Enrollment

100

Registered

2013-02-19

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intra-cerebral hemorrhage, diabetes mellitus

Interventions

Usual insulin therapy in the management of glycemic control Loose insulin therapy in the management of glycemic control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with acute intra-cerebral hemorrhage within 24 h onset 2)Prior diabetes or admission glucose >200mg/dl

Exclusion criteria

Exclusion criteria: 1)age <18 years 2)pregnancy 3)diabetic ketoacidosis 4)any premorbid condition that might have compromised evaluation and treatment (e.g. end stage of cancer) 5)traumatic intra-cerebral hemorrhage, subarachnoid hemorrhage, and vascular anomaly.

Design outcomes

Primary

Measure	Time frame
Hemorrhagic volume, neurological deterioration, and complication in acute phase and mRS at 90 days.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026